If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 171 - 180 of 278
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
Objective
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
Protocol No
PULM-SOS-II
Categories
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
Objective
Pulmonary Hypertension Screening for ILD for Earlier Detection
Protocol No
PULM-UNITED-PHINDER
Categories
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
Objective
Ralinepag in Subjects with PAH via an Open-label Extension
Protocol No
PULM-UNITED-ROR-PH-303
Categories
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Objective
Extension Study of Inhaled Treprostinil in Subjects With IPF
Protocol No
PULM-UNITED-TETON-OLE
Categories
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Objective
Prospective Observational Study of Clinical Utility of Envisia Genomic Classifier in Patients With Undiagnosed Interstitial Lung Disease
Protocol No
PULM-VERACYTE-ENVISIA-ILD
Categories
Measurement of Apathy in Systemic Lupus Erythematosus
Objective
Apathy in Lupus
Protocol No
RHEU-IIT-MCW-APATHY
Categories
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN)
Objective
Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy
Protocol No
NEPH-ALEXION-ALXN1210-IGAN-320
Categories
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases
Objective
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Protocol No
NRG-BN013
Categories
Cancer,
Other Skin,
Bladder,
Colorectal,
Cervix,
Other Gynecologic,
Breast Cancers,
Esophagus,
Prostate,
Larynx,
Other Gastrointestinal,
Esophagus,
Gynecologic Cancers,
Other Respiratory,
Melanoma, Skin,
Prostate and Urologic Cancers,
Pancreas/Liver,
Eye/Orbital Cancers,
Thoracic Cancers,
Lip, Oral Cavity and Pharynx,
Head and Neck Cancers,
Gastrointestinal Cancers,
Endocrine Cancers,
Skin Cancers,
Brain and Spine Cancers
REALITI-N: A Multinational, Observational Study to Evaluate the Real-World Effectiveness of Mepolizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Objective
Mepolizumab in CRSwNP
Protocol No
OTO-GSK-REALITI-N
Categories
REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)
Objective
Real World Experience with BRIUMVI for Relapsing MS
Protocol No
NEURO-TG-ENABLE